相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concomitant Treatment of Chronic Hepatitis C With Direct-Acting Antivirals and Multidrug-Resistant Tuberculosis Is Effective and Safe
Nara Melikyan et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Evolution and Revolution of Hepatitis C Management: From Non-A, Non-B Hepatitis Toward Global Elimination
Viktorija Basyte-Bacevice et al.
DIGESTIVE DISEASES (2020)
A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment
Russell R. Kempker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis
Maria Musso et al.
BMC INFECTIOUS DISEASES (2019)
Factors Associated With Sputum Culture-Negative vs Culture-Positive Diagnosis of Pulmonary Tuberculosis
Minh-Vu H. Nguyen et al.
JAMA NETWORK OPEN (2019)
Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine
Justin D. Lutz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Successful treatment of HCV/TB co-infected patient with sofosbuvir and daclatasvir: a case report
Braira Wahid et al.
FUTURE VIROLOGY (2018)
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid et al.
CLINICAL INFECTIOUS DISEASES (2016)
Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C
Polina German et al.
CLINICAL PHARMACOKINETICS (2016)
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
Brian J. Kirby et al.
CLINICAL PHARMACOKINETICS (2015)
Concordance of Sustained Virological Response 4, 12, and 24 Weeks Post-Treatment With Sofosbuvir-Containing Regimens for Hepatitis C Virus
Eric M. Yoshida et al.
HEPATOLOGY (2015)
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Abdullah Alsultan et al.
DRUGS (2014)
Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis
Nino Lomtadze et al.
PLOS ONE (2013)
Successful Antiviral and Antituberculosis Treatment With Pegylated Interferon-alfa and Ribavirin in a Chronic Hepatitis C Patient With Pulmonary Tuberculosis
Ming-Chao Tsai et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2009)
分享论文
